Implantable-cardioverter-defibrillator after ST-elevation myocardial infarction: when and how frequently is it implanted and what is the rate of appropriate interventions? Insight from Trieste registry

aCardiothoracovascular Department

bBiostatistics Unit, Department of Medical Sciences, University of Trieste, Trieste

cMOX - Modeling and Scientific Computing Laboratory, Department of Mathematics, Politecnico di Milano, Milan

dEmergency Department, Division of Cardiology, Gorizia & Monfalcone Hospital, ASUGI, Trieste, Italy

Correspondence to Prof. Gianfranco Sinagra, MD, FESC, Head of Cardiothoracovascular Department, University of Trieste, Italy, Via Valdoni 7, 34129 Trieste, Italy Tel: +39 040 3994477 4865; fax: +39 040 3994878; e-mail: [email protected]

Received 10 July, 2023

Revised 5 September, 2023

Accepted 16 September, 2023

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.jcardiovascularmedicine.com).

留言 (0)

沒有登入
gif